Axogen Surgical (AXGN) Enterprise Value to EBITDA Ratio
AxoGen, Inc. (AXGN) generates revenue from the sale of biomaterials and nerve regeneration conduits. The EV/EBITDA multiple history for the business on the GURU.Markets website visualizes this trend, where the 0.00 mark indicates the current state. This has solidified the company's status as a global leader in its niche, creating inelastic demand. Consequently, AxoGen, Inc. (AXGN) dominates the segment, protecting its market share due to the complexity of surgeon training.
Comprehensive metric breakdowns and analytics for axogeninc.com (AXGN)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
AXGN - Net Financial Result|Projected Future Earnings AxoGen, Inc.|AXGN - Price to Earnings Ratio|Forward P/E Multiple AxoGen, Inc.|AXGN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axogen Surgical|AXGN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Axogen|AXGN - Earnings per share for the trailing year|Quarterly EPS earnings growth axogeninc.com|AXGN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year AxoGen, Inc.
Analysis of all company metrics:Axogen Corp AXGN
AxoGen, Inc. (AXGN) investments in energy-efficient plants and eco-friendly packaging require significant capital expenditures, making debt load control critically important. The EV/EBITDA multiple dynamically correlates the total enterprise value, including debt, with operating profit before taxes and depreciation, allowing investors to assess the real value of assets relative to their ability to generate cash flow amid Fed rate volatility.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Autonomix Medical (AMIX) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio IVF|Enterprise Value to Operating Income Before Depreciation BBLG (Bone Biologics Corp.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|BIOL - Company Value to EBITDA|EV/EBITDA Multiple DYNT (Dynatronics)|Enterprise Value to EBITDA Multiple Paragon 28 Inc.|INVO Bio - EV/EBITDA Multiple
